AI
SUPN icon

Atom Investors’s Supernus Pharmaceuticals SUPN Stock Holding History

Atom Investors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Buy
79,936
+34,187
+75% +$1.64M 0.33% 42
2026
Q1 		$2.36M Buy
45,749
+41,233
+913% +$2.1M 0.17% 210
2025
Q4 		$224K Buy
+4,516
New +$220K 0.02% 489
2025
Q2 		– Sell
-8,795
Closed -$288K – 779
2025
Q1 		$288K Sell
8,795
-420
-5% -$14.9K 0.04% 365
2024
Q4 		$333K Sell
9,215
-62
-0.7% -$2.18K 0.04% 360
2024
Q3 		$289K Buy
9,277
+171
+2% +$5.34K 0.03% 380
2024
Q2 		$244K Buy
+9,106
New +$264K 0.02% 402

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Atom Investors's SUPN Position: Q2 2026 in Review

Atom Investors increased its Supernus Pharmaceuticals (SUPN) stake by 75% in Q2 2026, buying an estimated $1.64M and bringing the position to 79,936 shares worth $3.72M. The position accounts for 0.33% of the portfolio, ranked #42.

Atom Investors first reported a position in SUPN in Q2 2024 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Atom Investors held 79,936 shares of Supernus Pharmaceuticals worth $3.72M as of Q2 2026.
  • Atom Investors bought 34,187 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
  • Supernus Pharmaceuticals made up 0.33% of Atom Investors's portfolio in Q2 2026, its #42 holding.
  • Atom Investors first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.